Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment o (Q44725424)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment o |
scientific article |
Statements
1 reference
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment o (English)
1 reference
Yuhua Zhang
1 reference
Jun Xu
1 reference
Jeremy Levin
1 reference
Martin Hegen
1 reference
Guangde Li
1 reference
Heidi Robertshaw
1 reference
Fionula Brennan
1 reference
Terri Cummons
1 reference
Dave Clarke
1 reference
Nichole Vansell
1 reference
Cheryl Nickerson-Nutter
1 reference
Dauphine Barone
1 reference
Ken Mohler
1 reference
Roy Black
1 reference
Jerry Skotnicki
1 reference
Jay Gibbons
1 reference
Marc Feldmann
1 reference
Philip Frost
1 reference
Glenn Larsen
1 reference
Lih-Ling Lin
1 reference
12 January 2004
1 reference
1 reference
Identifiers
1 reference